Holen Sie sich die Stockscreener-App
31.76
2.48%
0.77
Handel nachbörslich:
31.76
Schlusskurs vom Vortag:
$30.99
Offen:
$30.77
24-Stunden-Volumen:
1.10M
Relative Volume:
0.58
Marktkapitalisierung:
$2.76B
Einnahmen:
$19.32M
Nettoeinkommen (Verlust:
$-141.47M
KGV:
-18.85
EPS:
-1.6851
Netto-Cashflow:
$-120.48M
1W Leistung:
-7.92%
1M Leistung:
-9.28%
6M Leistung:
+148.51%
1J Leistung:
+154.90%
1-Tages-Spanne:
$30.35
$32.33
1-Wochen-Bereich:
$29.30
$34.88
52-Wochen-Spanne:
$11.26
$36.41
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
31.76 | 2.70B | 19.32M | -141.47M | -120.48M | -1.6851 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-05-19 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Can Liquidia Corporation stock sustain market leadershipDouble Top/Bottom Patterns & Learn What Analysts Rate “Strong Buy” - ulpravda.ru
Liquidia Corporation Announces CEO Dr. Roger Jeffs to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Liquidia: Big Q3 Sales Print, But Voucher Starts And Inventory Can Distort Optics (LQDA) - Seeking Alpha
Liquidia stock slides after Needham swaps LQDA off its 2026 Conviction List - TechStock²
Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next - ts2.tech
Liquidia Corporation (NASDAQ:LQDA) Has Found A Path To Profitability - 富途牛牛
Liquidia stock drops 8% today as put-option hedging spikes — what’s next for LQDANEW YORK, Jan 2, 2026, 14:24 ET — Regular session - TechStock²
Stock Traders Purchase Large Volume of Liquidia Put Options (NASDAQ:LQDA) - MarketBeat
Liquidia (LQDA) Shares Decline Amid Market Movement - GuruFocus
Liquidia (NASDAQ:LQDA) Trading Down 5.6%Time to Sell? - MarketBeat
LIQUIDIA CORP (NASDAQ:LQDA) Emerges as a High-Growth Momentum and Trend Template Candidate - Chartmill
Liquidia Corporation (NASDAQ:LQDA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Liquidia (LQDA) Receives Reiterated 'Buy' Rating from BTIG Analy - GuruFocus
LQDA FinancialsIncome Statement - Quiver Quantitative
Liquidia (NASDAQ:LQDA) Receives "Buy" Rating from BTIG Research - MarketBeat
Assessing Liquidia (LQDA) Valuation After Bullish Analyst Reaffirmations and YUTREPIA Patent Uncertainty - simplywall.st
Liquidia Fails to Escape UTC Patent Suit Over Lung Drug Yutrepia - Bloomberg Law News
February 2026 Options Now Available For Liquidia (LQDA) - Nasdaq
How Liquidia’s Reaffirmed Analyst Support and Revenue Momentum Will Impact Liquidia (LQDA) Investors - simplywall.st
Liquidia Technologies stock hits 52-week high at 35.55 USD By Investing.com - Investing.com Canada
Liquidia Technologies stock hits 52-week high at 35.55 USD - Investing.com
Liquidia (LQDA) Climbs 10.7%, Nears 52-Week High on Strong Demand for Heart Treatment - MSN
Can Liquidia Corporation stock sustain free cash flow growthWeekly Stock Analysis & Community Consensus Trade Signals - Улправда
How Liquidia Corporation stock reacts to Fed rate cuts2025 Bull vs Bear & High Yield Stock Recommendations - Улправда
Breakouts Watch: Can Liquidia Corporation (LT4) stock sustain breakout momentumJuly 2025 Retail & Free Technical Pattern Based Buy Signals - ulpravda.ru
How Liquidia Corporation stock performs in weak economyStop Loss & Weekly High Return Stock Forecasts - Улправда
Can Liquidia Corporation stock deliver surprise earnings beatJuly 2025 Reactions & Free Fast Entry Momentum Trade Alerts - DonanımHaber
Will Liquidia Corporation (LT4) stock sustain bullish trend into 2025Dip Buying & Verified Momentum Stock Alerts - Улправда
Is It Too Late To Consider Liquidia After Its 182.6% 2025 Surge? - simplywall.st
Is It Too Late to Consider Liquidia After Its 1,051% Five Year Surge? - Yahoo Finance
Take the Zacks Approach to Beat the Markets: Liquidia, Western Digital & Johnson & Johnson in Focus - Yahoo Finance
Reassessing Liquidia (LQDA) Valuation After Yutrepia’s Strong Launch and Growing Institutional Confidence - simplywall.st
AWH Capital L.P. Takes $866,000 Position in Liquidia Corporation $LQDA - MarketBeat
Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA) - Yahoo Finance
HighVista Strategies LLC Sells 82,869 Shares of Liquidia Corporation $LQDA - MarketBeat
Velan Capital Investment Management LP Cuts Stock Position in Liquidia Corporation $LQDA - MarketBeat
Liquidia (NASDAQ:LQDA) Hits New 12-Month HighShould You Buy? - MarketBeat
Pale Fire Capital SE Invests $1.07 Million in Liquidia Corporation $LQDA - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Looks Just Right With A 30% Price Jump - simplywall.st
Assessing Liquidia (LQDA) Valuation After Strong Q3 Earnings Beat and Surging Yutrepia Sales - simplywall.st
Stonepine Capital Management LLC Invests $623,000 in Liquidia Corporation $LQDA - MarketBeat
How Liquidia Corporation stock compares to industry benchmarksJuly 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Why Liquidia Corporation (LT4) stock is trending on social mediaWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser
Will Liquidia Corporation (LT4) stock outperform small cap peers2025 Retail Activity & Low Drawdown Trading Techniques - Newser
What analysts say about Liquidia Corporation LT4 stockMoving Average Strategies & Beat the Market With Predictive Algorithms - earlytimes.in
Michael Kaseta Sells 1,166 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat
Liquidia (NASDAQ:LQDA) Insider Jason Adair Sells 693 Shares - MarketBeat
Liquidia (NASDAQ:LQDA) General Counsel Sells $34,507.68 in Stock - MarketBeat
Liquidia (NASDAQ:LQDA) Insider Scott Moomaw Sells 831 Shares - MarketBeat
Liquidia Technologies stock hits 52-week high at 32.96 USD - Investing.com
Liquidia Technologies stock hits 52-week high at 32.96 USD By Investing.com - Investing.com Canada
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Liquidia Corp-Aktie (LQDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Krepp Sarah | Chief Human Resource Officer |
Dec 01 '25 |
Sale |
32.19 |
221 |
7,114 |
141,218 |
| Kaseta Michael | CFO and COO |
Dec 01 '25 |
Sale |
32.19 |
1,166 |
37,534 |
353,823 |
| Boyle Dana | Chief Accounting Officer |
Dec 01 '25 |
Sale |
32.19 |
303 |
9,754 |
155,031 |
| Adair Jason | Chief Business Officer |
Dec 01 '25 |
Sale |
32.19 |
693 |
22,308 |
175,868 |
| Moomaw Scott | Chief Commercial Officer |
Dec 01 '25 |
Sale |
32.19 |
831 |
26,750 |
154,506 |
| Adair Jason | Chief Business Officer |
Nov 18 '25 |
Option Exercise |
5.89 |
35,656 |
210,014 |
210,654 |
| Adair Jason | Chief Business Officer |
Nov 18 '25 |
Sale |
30.03 |
35,656 |
1,070,710 |
174,998 |
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):